ArticleClinical lymphoma, myeloma & leukemia2026
Impact of Measurable Residual Disease Status on Outcomes After HLA-Matched Donor Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia.
Moazzam Shahzad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.